SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013614
Filing Date
2020-11-12
Accepted
2020-11-12 08:16:08
Documents
88
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20200930x10q.htm 10-Q 1946978
2 EX-31.1 aplt-20200930ex3113fb1b2.htm EX-31.1 8490
3 EX-31.2 aplt-20200930ex3127e9210.htm EX-31.2 8483
4 EX-32.1 aplt-20200930ex3210b909d.htm EX-32.1 5788
5 EX-32.2 aplt-20200930ex3226064be.htm EX-32.2 5933
  Complete submission text file 0001558370-20-013614.txt   8194734

Data Files

Seq Description Document Type Size
6 EX-101.INS aplt-20200930.xml EX-101.INS 1726922
7 EX-101.SCH aplt-20200930.xsd EX-101.SCH 70150
8 EX-101.CAL aplt-20200930_cal.xml EX-101.CAL 52237
9 EX-101.DEF aplt-20200930_def.xml EX-101.DEF 265864
10 EX-101.LAB aplt-20200930_lab.xml EX-101.LAB 548611
11 EX-101.PRE aplt-20200930_pre.xml EX-101.PRE 460536
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 201303532
SIC: 2834 Pharmaceutical Preparations